Link Pharma Chem Ltd
The short version
A shrinking, thinly profitable business — priced at a steep premium to what it earns.
What Link Pharma Chem does
Incorporated in 1986, Link Pharma Chem Ltd is in the business of manufacturing and job work of organic intermediate
Worked out from Link Pharma Chem's own filed results and exchange data, in plain words. Where a finance term matters, we say what it means.
01What does it do?
Link Pharma Chem is a micro-sized company in commodity chemicals.
Incorporated in 1986, Link Pharma Chem Ltd is in the business of manufacturing and job work of organic intermediate
- Whole company is worth
- ₹12 crore
- Run by
- Rishikesh Thakur
- Shareholders
- 6,019 people
- Listed since
- 1995
A very small company by stock-market value — prices can swing hard and trading can be thin.
02Is it growing?
Sales have shrunk 5% a year for 5 years.
Profit, though, fell 41% a year over the same stretch.
03Does it make money?
Out of every ₹100 it sells, it keeps ₹0.3 as profit.
Here is where the money from Link Pharma Chem's sales went in FY26, the latest full year it has reported.
- ₹39Making or buying what it sellsraw materials, stock, goods bought for resale
- ₹55Running the businessstaff, rent, marketing, power and everything else
- ₹1.9Interest on its loansthe cost of borrowed money
- ₹3.6Wear and tearmachines, stores and buildings losing value over time
- ₹0.2Taxincome tax paid to the government
- ₹0.3Profit it keepswhat is left for the company's owners
On the money its owners have put in
It earns ₹1 a year on every ₹100 its owners have invested.
That figure is called return on equity (ROE). Under ₹12 is a thin return for the risk of owning shares. For comparison, a bank fixed deposit pays roughly ₹6–7.
04Is the price high or low?
You pay ₹159 for every ₹1 of profit it makes in a year.
This is the P/E ratio: share price divided by a year's profit per share. A P/E of 159 means buyers are paying for about 159 years of today's profit up front.
The share price over the past year
It is 23% below its highest price of the past year and 29% above its lowest.
05Who owns it?
Its founders and parent group own 52 of every 100 shares — they control the company.
If the company were split into 100 equal shares, this is who would hold them. 6,019 people and institutions hold its shares.
As filed for the quarter ending 30 Sept 2026. Arrows show the change since the quarter before, in percentage points.
06What is going well, and what to watch
The figures raise more questions than they answer.
Picked out of the numbers above by fixed rules — the same rules for every company — so nothing here is somebody's opinion.
Going well
Nothing stands out in its favour in the figures we have.
Worth watching
- Sales have been shrinking — 5% a year.
- The share price is 159 times a year's profit, so it leans heavily on growth continuing.
- Thinly traded — only about ₹1 lakh of shares change hands a day, so buying or selling can move the price.
07What happened lately?
Latest quarter: sales up 12%, profit down 20%.
Apr–Jun 2026 is the most recent quarter it has reported. Each figure is compared with the same three months a year earlier, because many businesses sell more in some seasons than others.
Sales
₹8.8 Cr
▲ 12.3% on a year earlier
Profit
₹0.3 Cr
▼ 20.0% on a year earlier
No notable developments in the last few weeks.
Advanced view
Every number, every table, the full chart.
Ten years of statements, quarterly results, peers side by side, technical indicators, analyst estimates, bulk deals and filings.
Ask DoXy
Still have a question about Link Pharma Chem?
This page describes Link Pharma Chem using its reported figures and exchange data. It is for information only and is not investment advice or a recommendation to buy, sell or hold. DocStoX is not a SEBI-registered investment adviser or research analyst.
Link Pharma Chem Ltd (LINKPH): company summary
The company's annual revenue rose 7.9% to ₹27 crore, but net profit remained at ₹0 crore, swinging from a net loss of ₹1 crore.
Link Pharma Chem Ltd (LINKPH) is a micro-cap Chemicals company valued at ₹12 crore operating in Commodity Chemicals on the NSE and BSE.
- Recent price move
- Link Pharma Chem Ltd last traded at ₹27, unchanged on the day.
- Recent developments
- On 2026-06-30, the company reported its latest quarter results, showing revenue at ₹9 crore, matching the prior year's quarter but with no net profit. There are no recent developments reported in the provided facts.
- Financial performance
- The company's annual revenue rose 7.9% to ₹27 crore, but net profit remained at ₹0 crore, swinging from a net loss of ₹1 crore. In the latest quarter, revenue increased 12.3% to ₹9 crore, but net profit stayed at ₹0 crore, declining 20.0% compared to the same quarter a year earlier.
- Valuation multiples
- The stock trades at 158.8 times earnings, 0.95 times book value.
- Things to watch
- The company has not generated a net profit in the latest quarter or the past four quarters, with net profit remaining at ₹0 crore. The net profit margin improved to 0.3% from -4.0% but still indicates no profitability. The stock is 22.7% below its 52-week high, and the company's profit has declined sharply over the past five years.
- Where it stands
- The company's revenue grew 7.9% annually but remains unprofitable, with net profit at ₹0 crore. The latest quarter saw revenue rise 12.3% but no change in net profit. The stock is 22.7% below its 52-week high, and the company's profit has declined sharply over the past five years.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
More Chemicals stocks · Commodity Chemicals
Explore Link Pharma Chem Ltd’s valuation
Free deep-dive tools · no sign-up
Link Pharma Chem Ltd peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Link Pharma Chem Ltd with the ratios and calculators DocStoX uses in its analysis.

